{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:55:03Z","timestamp":1786377303931,"version":"build-2736575974"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We sought to explore relationships of acute dissociative effects of intravenous ketamine with change in depression and suicidal ideation and with plasma metabolite levels in a randomized, midazolam-controlled trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data from a completed trial in suicidal, depressed participants (n\u2009=\u200940) randomly assigned to ketamine was used to examine relationships between ketamine treatment\u2013emergent dissociative and psychotomimetic symptoms with pre\/post-infusion changes in suicidal ideation and depression severity. Nonparametric correlational statistics were used. These methods were also used to explore associations between dissociative or psychotomimetic symptoms and blood levels of ketamine and metabolites in a subset of participants (n\u2009=\u200928) who provided blood samples immediately post-infusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Neither acute dissociative nor psychotomimetic effects of ketamine were associated with changes in suicidal ideation or depressive symptoms from pre- to post-infusion. Norketamine had a trend-level, moderate inverse correlation with dissociative symptoms on Day 1 post-injection (P \u2009=\u2009.064; P =.013 removing 1 outlier). Dehydronorketamine correlated with Clinician-Administered Dissociative States Scale scores at 40 minutes (P\u2009=\u2009.034), 230 minutes (P\u2009=\u2009.014), and Day 1 (P\u2009=\u2009.012).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We did not find evidence that ketamine\u2019s acute, transient dissociative, or psychotomimetic effects are associated with its antidepressant or anti-suicidal ideation actions. The correlation of higher plasma norketamine with lower dissociative symptoms on Day 1 post-treatment suggests dissociation may be more an effect of the parent drug.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijnp\/pyae017","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T14:06:20Z","timestamp":1712239580000},"source":"Crossref","is-referenced-by-count":11,"title":["Acute Dissociation and Ketamine\u2019s Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial"],"prefix":"10.1093","volume":"27","author":[{"given":"Sumra","family":"Sajid","sequence":"first","affiliation":[{"name":"New York State Psychiatric Institute , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanga C","family":"Galfalvy","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center and New York State Psychiatric Institute , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G","family":"Keilp","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center and New York State Psychiatric Institute , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainsley K","family":"Burke","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center and New York State Psychiatric Institute , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J John","family":"Mann","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center and New York State Psychiatric Institute , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Grunebaum","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center and New York State Psychiatric Institute , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"2024042707410046700_CIT0001","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","volume":"43","author":"Abdallah","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"2024042707410046700_CIT0002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpsychires.2020.06.012","article-title":"Can \u2018floating\u2019 predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression","volume":"130","author":"Acevedo-Diaz","year":"2020","journal-title":"J Psychiatr Res"},{"key":"2024042707410046700_CIT0003","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine\u2019s antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat Commun"},{"key":"2024042707410046700_CIT0004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the Scale for Suicide Ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J Consult Clin Psychol"},{"key":"2024042707410046700_CIT0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6","article-title":"Scale for suicide ideation: psychometric properties of a self-report version","volume":"44","author":"Beck","year":"1988","journal-title":"J Clin Psychol"},{"key":"2024042707410046700_CIT0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"2024042707410046700_CIT0007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00005053-198612000-00004","article-title":"Development, reliability, and validity of a dissociation scale","volume":"174","author":"Bernstein","year":"1986","journal-title":"J Nerv Ment Dis"},{"key":"2024042707410046700_CIT0008","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/15299732.2020.1869652","article-title":"Childhood abuse experiences, depression and dissociation symptoms in relation to suicide attempts and suicidal ideation","volume":"22","author":"Bertule","year":"2021","journal-title":"J Trauma Dissociation"},{"key":"2024042707410046700_CIT0009","doi-asserted-by":"crossref","first-page":"78","DOI":"10.32481\/djph.2022.05.010","article-title":"Trauma-related dissociation and the dissociative disorders: neglected symptoms with severe public health consequences","volume":"8","author":"Boyer","year":"2022","journal-title":"Dela J Public Health"},{"key":"2024042707410046700_CIT0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative States with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"2024042707410046700_CIT0011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.psc.2005.10.004","article-title":"Normative dissociation","volume":"29","author":"Butler","year":"2006","journal-title":"Psychiatr Clin North Am"},{"key":"2024042707410046700_CIT0012","doi-asserted-by":"crossref","first-page":"20m13232","DOI":"10.4088\/JCP.20m13232","article-title":"Happiness during low-dose ketamine infusion predicts treatment response: reexploring the adjunctive ketamine study of taiwanese patients with treatment-resistant depression","volume":"81","author":"Chen","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"2024042707410046700_CIT0013","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2147\/NDT.S135623","article-title":"Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review","volume":"13","author":"Correia-Melo","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2024042707410046700_CIT0014","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"Am J Psychiatry"},{"key":"2024042707410046700_CIT0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","article-title":"Ketamine Assisted Psychotherapy (KAP): patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy","volume":"51","author":"Dore","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"2024042707410046700_CIT0016","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","article-title":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression","volume":"45","author":"Farmer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2024042707410046700_CIT0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/15299732.2020.1760168","article-title":"A preliminary investigation of depression in people with pathological dissociation","volume":"21","author":"Fung","year":"2020","journal-title":"J Trauma Dissociation"},{"key":"2024042707410046700_CIT0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpsychires.2022.07.054","article-title":"Prevalence and correlates of dissociative symptoms among people with depression","volume":"154","author":"Fung","year":"2022","journal-title":"J Psychiatr Res"},{"key":"2024042707410046700_CIT0019","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"2024042707410046700_CIT0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2024042707410046700_CIT0021","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jpsychires.2019.08.005","article-title":"Ketamine metabolite pilot study in a suicidal depression trial","volume":"117","author":"Grunebaum","year":"2019","journal-title":"J Psychiatr Res"},{"key":"2024042707410046700_CIT0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024042707410046700_CIT0023","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/clinchem\/47.9.1713","article-title":"Stability of ketamine and its metabolites norketamine and dehydronorketamine in human biological samples","volume":"47","author":"Hijazi","year":"2001","journal-title":"Clin Chem"},{"key":"2024042707410046700_CIT0024","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.bja.2020.06.067","article-title":"Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis","volume":"125","author":"Kamp","year":"2020","journal-title":"Br J Anaesth"},{"key":"2024042707410046700_CIT0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"2024042707410046700_CIT0026","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/jm00161a043","article-title":"Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine","volume":"29","author":"Leung","year":"1986","journal-title":"J Med Chem"},{"key":"2024042707410046700_CIT0027","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/schbul\/sbaa037","article-title":"The relationship between dissociation and symptoms of psychosis: a meta-analysis","volume":"46","author":"Longden","year":"2020","journal-title":"Schizophr Bull"},{"key":"2024042707410046700_CIT0028","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"J Affect Disord"},{"key":"2024042707410046700_CIT0029","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1073\/pnas.1816071116","article-title":"Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function","volume":"116","author":"Lumsden","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024042707410046700_CIT0030","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics Promote Structural and Functional Neural Plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Reports"},{"key":"2024042707410046700_CIT0031","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00213-023-06324-8","article-title":"Reconsidering \u201cdissociation\u201d as a predictor of antidepressant efficacy for esketamine","volume":"240","author":"Mathai","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"2024042707410046700_CIT0032","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"2024042707410046700_CIT0033","volume-title":"Manual for the Profile of Mood States","author":"McNair","year":"1981"},{"key":"2024042707410046700_CIT0034","doi-asserted-by":"crossref","first-page":"e2013211","DOI":"10.1001\/jamanetworkopen.2020.13211","article-title":"Assessment of relationship of ketamine dose with magnetic resonance spectroscopy of Glx and GABA responses in adults with major depression: a randomized clinical trial","volume":"3","author":"Milak","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024042707410046700_CIT0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","article-title":"Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in \u03b17 nicotinic acetylcholine receptors","volume":"698","author":"Moaddel","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"2024042707410046700_CIT0036","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"2024042707410046700_CIT0037","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"2024042707410046700_CIT0038","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jad.2018.02.049","article-title":"Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression","volume":"232","author":"Niciu","year":"2018","journal-title":"J Affect Disord"},{"key":"2024042707410046700_CIT0039","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"2024042707410046700_CIT0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchromb.2008.09.036","article-title":"Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry","volume":"876","author":"Parkin","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2024042707410046700_CIT0041","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2014.12.011","article-title":"PTSD, emotion dysregulation, and dissociative symptoms in a highly traumatized sample","volume":"61","author":"Powers","year":"2015","journal-title":"J Psychiatr Res"},{"key":"2024042707410046700_CIT0042","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"2024042707410046700_CIT0043","article-title":"Ketamine","volume-title":"StatPearls","author":"Rosenbaum","year":"2023"},{"key":"2024042707410046700_CIT0044","doi-asserted-by":"crossref","first-page":"171","DOI":"10.9758\/cpn.2014.12.3.171","article-title":"The many faces of dissociation: opportunities for innovative research in psychiatry","volume":"12","author":"\u015ear","year":"2014","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2024042707410046700_CIT0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000497441","article-title":"The altered-state-of-consciousness (ASC) aspect of a feeling of lightness is reported to be associated with antidepressant benefits by depressed individuals receiving ketamine infusions: A systematic analysis of internet video testimonials","volume":"88","author":"Stocker","year":"2019","journal-title":"Psychother Psychosom"},{"key":"2024042707410046700_CIT0046","doi-asserted-by":"crossref","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of Consciousness Rating Scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"2024042707410046700_CIT0047","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Res"},{"key":"2024042707410046700_CIT0048","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers. Studies in volunteers","volume":"57","author":"White","year":"1985","journal-title":"Br J Anaesth"},{"key":"2024042707410046700_CIT0049","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2024042707410046700_CIT0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother Psychosom"},{"key":"2024042707410046700_CIT0051","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2307\/1423648","article-title":"Measuring dissociation: comparison of alternative forms of the dissociative experiences scale","volume":"112","author":"Wright","year":"1999","journal-title":"Am J Psychol"},{"key":"2024042707410046700_CIT0052","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"2024042707410046700_CIT0053","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2024042707410046700_CIT0055","first-page":"856","article-title":"A randomized trial of an n-methyl-d-aspartate antagonist in treatment-resistant major depression","volume-title":"Arch Gen Psychiatry","author":"Zarate","year":"2006"},{"key":"2024042707410046700_CIT0054","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine\u2019s plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyae017\/57160480\/pyae017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/27\/4\/pyae017\/57343357\/pyae017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/27\/4\/pyae017\/57343357\/pyae017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T07:41:48Z","timestamp":1714203708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyae017\/7640766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyae017","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,4,1]]},"article-number":"pyae017"}}